Aimmune Therapeutics AR101 peanut allergy
Aimmune starts POSEIDON trial to treat peanut allergy
Aimmune Therapeutics has commenced the Peanut Oral Immunotherapy Study of Early Intervention for Desensitisation (POSEIDON) trial. POSEIDON is a Phase…
Aimmune Therapeutics has commenced the Peanut Oral Immunotherapy Study of Early Intervention for Desensitisation (POSEIDON) trial. POSEIDON is a Phase…